Vivos Therapeutics Doubles Nevada Capacity with New Sleep Apnea Facility
Event summary
- Vivos Therapeutics opened a new sleep testing and treatment facility in Henderson, Nevada, on August 27, 2026.
- The facility is expected to more than double annual revenue production capacity to over $10 million.
- The center will employ up to 30 personnel, including medical doctors, dentists, and nurse practitioners.
- The company has seen incoming referrals more than double in the Las Vegas market since May-June 2026.
The big picture
Vivos Therapeutics' new facility in Henderson, Nevada, underscores the growing demand for non-invasive sleep apnea treatments. The company's focus on integrated diagnostic and treatment services positions it to capitalize on the underserved market of undiagnosed sleep apnea patients. With over 200,000 Nevadans living with undiagnosed sleep apnea, the facility's impact on the company's revenue and market position will be closely watched.
What we're watching
- Revenue Impact
- How the new facility will affect Vivos Therapeutics' revenue growth in the Las Vegas market.
- Patient Demand
- Whether the company can sustain the recent surge in patient referrals and convert them into revenue.
- Operational Scaling
- The pace at which Vivos Therapeutics can scale its operations to meet growing demand.
Related topics